The 13-valent pneumococcal conjugated vaccine introduction in subjects aged> 50 years: the result of a Health Technology Assessment

Maria Lucia Specchia, Maria Luisa Di Pietro, Chiara Cadeddu, Pietro Refolo, Gualtiero Ricciardi, Chiara De Waure, Silvio Capizzi, Francesco Di Nardo, Anna Maria Ferriero, Maria Assunta Veneziano, Maria Rosaria Gualano, Nicola Nicolotti, Antonella Sferrazza, Maria Daniela Gliubizzi, Giuseppe La Torre, Flavia Kheiraoui, L Mantovani, G Furneri, R Saulle

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Streptococcus pneumoniae (Spn) is a common cause of Community-Acquired Pneumonia (CAP) and Invasive Pneunmococcal Diseases (IPD). Risk for infection increases in particular in elderly. The aim of the study was to evaluate the introduction of 13-valent conjugate pneumococcal vaccine (PCV13) among patients ≥50 years.
Lingua originaleEnglish
pagine (da-a)284-285
Numero di pagine2
RivistaEuropean Journal of Public Health
DOI
Stato di pubblicazionePubblicato - 2013

Keywords

  • health technology assessment

Fingerprint

Entra nei temi di ricerca di 'The 13-valent pneumococcal conjugated vaccine introduction in subjects aged> 50 years: the result of a Health Technology Assessment'. Insieme formano una fingerprint unica.

Cita questo